Replies to post #239 on Ocular Therapeutix Inc (OCUL)

[Whalatane]

Hi N7 I generally hold thru trial results and then " sell the news " if positive .
Launching new drugs usually takes more $ and longer then most expect

Company presentation scheduled on Monday, January 13th at 5:15 PM PT

Ocular to provide enrollment update for SOL-R, Ocular’s second registrational trial of AXPAXLI™ in wet AMD, future opportunities for AXPAXLI, and a general corporate overview

If you're interested in Co suggest you listen to the JPM presentation

Kiwi